Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1043 of 6351
-
Promising cocktail of targeted drugs and chemo takes on mantle cell lymphoma
Disease control OngoingThis phase II trial studies how well ibrutinib and rituximab given together with venetoclax and combination chemotherapy work in treating patients with newly diagnosed mantle cell lymphoma. Ibrutinib may stop the growth of tumor cells by blocking some of the enzymes needed for ce…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a brain drug curb meth addiction?
Disease control CompletedAddiction to methamphetamine is a serious health problem in the United States. Right now, there are no medications that a doctor can give someone to help them stop using methamphetamine. More research is needed to develop drugs for methamphetamine addiction. Ibudilast (the study …
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Faster pregnancy after novel uterine repair surgery?
Disease control CompletedTo investigate whether a novel hysteroscopic-assisted transvaginal repair technique results in a shorter time to pregnancy and superior fertility outcomes compared to traditional transvaginal repair.
Sponsor: International Peace Maternity and Child Health Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:39 UTC
-
New triple therapy could improve diabetes control
Disease control OngoingTo assess whether the addition of dapagliflozin to semaglutide and insulin (triple therapy) improves glycemic control in patients with type 1 diabetes compared with semaglutide and insulin (dual therapy) and insulin only (standard) treatment.
Phase 2/3 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows promise for rare lung cancer
Disease control CompletedThe aim of this clinical trial is to assess the effect of treatment with a monoclonal antibody called atezolizumab in patients diagnosed with a type of lung cancer called malignant pleural mesothelioma. The efficacy (whether the treatment works), safety and tolerability (side eff…
Phase 3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for lung cancer patients: lorlatinib targets resistant tumors
Disease control CompletedA Phase 2, multi center, open label, dual cohort study to evaluate the efficacy and safety of lorlatinib (PF 06463922) monotherapy in ALK inhibitor treated locally advanced or metastatic ALK positive non small cell lung cancer patients in China
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
HPV vaccine shows promise for chinese women and girls in large trial
Vaccine CompletedThis study investigates the immunogenicity and safety of the 9vHPV vaccine in healthy Chinese females 9 to 45 years of age. The study consists of Stage I (Day 1 to Month 7) and Stage II (post Month 7 to Month 60). Stage II will report the long-term immunogenicity and safety in th…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Vaccine
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo aims to tackle Hard-to-Treat cancers
Disease control OngoingThe main purpose of this study is to establish the safety and the recommended dose of TRK-950 in combination with FOLFIRI, Gemcitabine / Cisplatin, Gemcitabine / Carboplatin, Ramucirumab / Paclitaxel, PD1 inhibitors (Nivolumab or Pembrolizumab), and Imiquimod Cream, Bevacizumab, …
Phase 1 • Sponsor: Toray Industries, Inc • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can smarter imaging make ultrasound therapy for tremors more precise?
Disease control CompletedThe objective of this study is to evaluate the safety and feasibility of Auto Focusing (AF) echo imaging using the ExAblate Neuro system
Sponsor: InSightec • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New biologic drug aims to ease pain in hidden arthritis
Disease control CompletedThe purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active nonradiographic axial spondyloarthritis (nr-axSpA).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug shows promise for back pain from ankylosing spondylitis
Disease control CompletedThe purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active ankylosing spondylitis (AS).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Eye drops may curb worsening nearsightedness in kids
Disease control CompletedMyopia, or nearsightedness, is the most common eye disorder, often affecting more than 40% of adults in Europe, Asia and the USA. Severe myopia is associated with an increased risk of developing other eye conditions such as glucoma, cataracts and retinal detachment, which may lea…
Phase 3 • Sponsor: Sydnexis, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New immune cell therapy takes on Hard-to-Treat myeloma
Disease control PausedThis phase I trial studies the side effects and best dose of CS1-chimeric antigen receptor (CAR) T therapy after chemotherapy in treating patients who have CS1 positive multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory). Immune cells can …
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for rare seizure patients: Long-Term drug safety confirmed
Disease control CompletedThis is an international, multicenter, open-label, long-term safety study of ZX008 in subjects with Dravet syndrome, Lennox-Gastaut syndrome or epileptic encephalopathy
Phase 3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Lung cancer showdown: which targeted pill works better after crizotinib fails?
Disease control CompletedBrigatinib is a medicine that binds to the surface of tumor cells in some cancers and delivers a dose of chemotherapy directly to the tumor. In this study, participants will be people with non-small-cell lung cancer (NSCLC for short). The main aim of the study is to learn if brig…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 26, 2026 16:05 UTC
-
Could cheap steroids help hearts in shock?
Disease control CompletedThe purpose of this randomized controlled trial is to evaluate the hemodynamic effect of low dose corticosteroid therapy (hydrocortisone and fludrocortisone) in the treatment of adult cardiogenic shock.
Phase 3 • Sponsor: CMC Ambroise Paré • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a Father-Focused program curb HIV, substance abuse, and violence?
Prevention CompletedThe overall objective of this project is to adapt and enhance HoMBReS (Hispanic Men Building Respect, Education, and Safety within Families /Hombres Manteniendo Respeto, Educacion y Seguridad de Familia), a Center for Disease Control (CDC)-identified best-evidence HIV behavioral …
Sponsor: University of Miami • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
New stem cell transplant trial aims to control tough lymphoma
Disease control OngoingBackground: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause. Objective: To test if a stem cell transplant can cure or control lymphoma. Also to test i…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New HIV vaccines enter human safety trials
Vaccine Recruiting nowBackground: Researchers want see if three new HIV (human immunodeficiency virus) vaccines are safe. Two vaccines are carried by live adenoviruses, which are natural and typically cause cold symptoms or an eye infection. Researchers want to see if all the vaccines help fight HIV …
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
Can a stool transplant calm an inflamed pouch?
Disease control CompletedThis is a randomized double-blind placebo controlled trial involving a single centre (McMaster University) recruiting patients from Hamilton, ON and the surrounding regions, to evaluate whether fecal microbiota transplantation once weekly for six weeks increases the remission rat…
Phase 2 • Sponsor: McMaster University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC